Editor’s Note: In Tuesday’s issue, we looked at comments from 340B provider stakeholders, today we look more closely at the [...] …
Articles by : Shannon Young, Associate Editor/Senior Writer
A Canadian drug manufacturer recently announced that it will refund covered entities for hundreds of different products purchased between 2021 [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Editor’s Note: In today’s issue, we look at the 340B provider community’s comments to CMS. In a future issue, we [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
A Japanese drug manufacturer has ended its 340B contract pharmacy restrictions in Maryland and Mississippi in conjunction with new contract [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Two major drug manufacturers are suing Minnesota to block a new 340B contract pharmacy access law, which took effect this [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Two major drug manufacturers this week sued Kansas in an effort to block the state’s new contract pharmacy access law, [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Groups representing Maryland providers along with national advocacy groups recently urged a federal judge to reject Novartis’ attempt to block [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Dozens of hospitals in Texas and other states have filed suits against Department of Health and Human Services (HHS) Secretary [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
The New York Times has sued the federal agency tasked with overseeing the 340B program to force the release of [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Correction, Thursday, July 27, 2024, 7:00 p.m. EDT—The original version of this article mistakenly said Minnesota’s contract pharmacy access law [...] …